Clene (CLNN) Price to Earnings (2020 - 2026)
Clene (CLNN) posted Price to Earnings of 5.86 for Q2 2026, up 65.66% on a QoQ basis from 17.07 in Q4 2025, and down 17.59% year-over-year from 7.11 in Q2 2025.
Powered by 
Analysis
Clene (CLNN) Price to Earnings (2020 - 2026) Analysis & Trends
Clene has reported Price to Earnings for 7 years, with the latest figure at 5.86 in Q2 2026.
- On a quarterly basis, Price to Earnings fell 17.59% year-over-year to 5.86 in Q2 2026; TTM through Jun 2026 was 2.36, a 36.75% decrease from a year earlier, with the FY2025 full-year figure at 3.08, down 123.22% from the prior year.
- Price to Earnings was 5.86 for Q2 2026 at Clene, up from 17.07 in the prior quarter.
- The five-year high for Price to Earnings was 149.91 in Q4 2023, with the low at 35.55 in Q1 2025.
- Average Price to Earnings over 5 years is 2.2, with a median of 7.02 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: Price to Earnings surged 948.35% in 2023, then slumped 613.2% in 2025.
- Over 5 years, Price to Earnings stood at 14.3 in 2022, then soared by 948.35% to 149.91 in 2023, then plunged by 105.43% to 8.14 in 2024, then tumbled by 109.84% to 17.07 in 2025, then jumped by 65.66% to 5.86 in 2026.
- The last three Price to Earnings figures came in at 5.86 (Q2 2026), 17.07 (Q4 2025), and 7.02 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.86 |
| Dec 31, 2025 | -17.07 |
| Sep 30, 2025 | -7.02 |
| Jun 30, 2025 | -4.99 |
| Mar 31, 2025 | -35.55 |
| Dec 31, 2024 | -8.14 |
| Sep 30, 2024 | -3.94 |
| Jun 30, 2024 | -6.83 |
| Mar 31, 2024 | -4.98 |
| Dec 31, 2023 | 149.91 |
| Sep 30, 2023 | -26.55 |
| Jun 30, 2023 | -3.01 |
| Mar 31, 2023 | -7.49 |
| Dec 31, 2022 | 14.30 |
| Sep 30, 2022 | -16.21 |
| Jun 30, 2022 | -35.25 |
| Mar 31, 2022 | -18.66 |
| Dec 31, 2021 | 41.68 |
| Sep 30, 2021 | 14.67 |
| Jun 30, 2021 | -203.54 |